Not applicableNot Yet RecruitingNCT06218719What this trial is testingStudying Patterns in Patient Engagement Among Tardive Dyskinesia PatientsWho this might be right forTardive Dyskinesia Power Life Sciences Inc. 500
Post-approval studies (Phase 4)UnknownNCT00468533What this trial is testingThe Monitor of Serum Prolactin Level in a 3 Months Aripiprazole TrialWho this might be right forSchizophrenia, Tardive Dyskinesia, Metabolic Syndrome Yu-Li Hospital 50
Large-scale testing (Phase 3)WithdrawnNCT03254186What this trial is testingSafety and Efficacy of Propranolol in the Treatment of Tardive DyskinesiaWho this might be right forTardive Dyskinesia Emory University
Large-scale testing (Phase 3)Study completedNCT01543321What this trial is testingXenazine in Late Dyskinetic Syndrome With NeurolepticsWho this might be right forTardive Dyskinesia Centre Hospitalier Universitaire, Amiens 54
Post-approval studies (Phase 4)WithdrawnNCT06107829What this trial is testingValbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental DisabilitiesWho this might be right forTardive DyskinesiaIntellectual DisabilityDevelopmental Disabilities Stephen Ruedrich
Post-approval studies (Phase 4)Study completedNCT00926965What this trial is testingTardive Dyskinesia and Cognitive FunctionWho this might be right forTardive DyskinesiaNeurocognitive Function Taipei Veterans General Hospital, Taiwan 80
Post-approval studies (Phase 4)Study completedNCT05859698What this trial is testingStudy of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive DyskinesiaWho this might be right forSchizophreniaSchizoaffective DisorderBipolar Disorder+2 more Neurocrine Biosciences 59
Not applicableEnded earlyNCT00310661What this trial is testingSarizotan in the Treatment of Neuroleptic-induced Tardive DyskinesiaWho this might be right forNeuroleptic-induced Tardive Dyskinesia Centre for Addiction and Mental Health 60
Not applicableActive Not RecruitingNCT02252380What this trial is testingExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement DisordersWho this might be right forMovement DisordersEssential TremorHolmes Tremor+6 more InSightec 10
Not applicableStudy completedNCT03287778What this trial is testingRandomized Controlled Trial of Pyridoxine for Tardive DyskinesiaWho this might be right forTardive DyskinesiaAntipsychotic Agents University of North Carolina, Chapel Hill 17
Not applicableEnded earlyNCT02524886What this trial is testingDeep Brain Stimulation for Patients With Tardive Dyskinesia and or DystoniaWho this might be right forTardive DyskinesiaTardive Dystonia GGZ Centraal 1
Large-scale testing (Phase 3)Study completedNCT00190008What this trial is testingPiracetam for Treatment Tardive DyskinesiaWho this might be right forTardive Dyskinesia Beersheva Mental Health Center 40
Testing effectiveness (Phase 2)Study completedNCT02500628What this trial is testingHeart Rate Variability in Response to Metformin ChallengeWho this might be right forFibromyalgiaMitochondrial DiseasesMovement Disorders+1 more Woodinville Psychiatric Associates 61
Large-scale testing (Phase 3)Study completedNCT03176771What this trial is testingEfficacy and Safety of MT-5199 in Subjects With Tardive DyskinesiaWho this might be right forTardive Dyskinesia Tanabe Pharma Corporation 256
Testing effectiveness (Phase 2)Looking for participantsNCT06731868What this trial is testingSafety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive DyskinesiaWho this might be right forTardive Dyskinesia (TD) Luye Pharma Group Ltd. 120
Post-approval studies (Phase 4)Study completedNCT00164242What this trial is testingTreatment of Tardive Dyskinesia With GalantamineWho this might be right forTardive Dyskinesia Caroff, Stanley N., M.D. 36
Early research (Phase 1)Study completedNCT06216054What this trial is testingSafety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy SubjectsWho this might be right forTardive DyskinesiaHuntington Disease Luye Pharma Group Ltd. 40
Post-approval studies (Phase 4)Study completedNCT03891862What this trial is testingPersistence of Effect and Safety of Valbenazine for the Treatment of Tardive DyskinesiaWho this might be right forTardive Dyskinesia (TD) Neurocrine Biosciences 135
Early research (Phase 1)Study completedNCT05238701What this trial is testingA Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy SubjectsWho this might be right forHuntington DiseaseTardive Dyskinesia Luye Pharma Group Ltd. 104
Testing effectiveness (Phase 2)Study completedNCT01176721What this trial is testingTranscutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of SchizophreniaWho this might be right forSchizophrenia cerbomed GmbH 20